Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Arcoral Pharma (Arcoral Tab)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Rights of an oncology support care drug. The drug is a topical oral agent used in the treatment of conditions resulting in reduced salivary flow such as xerostomia and hyposalivation caused by radiotherapy, mucositis, surgery, Sjögrens syndrome or obstruction of the salivary glands.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • Hokksund
  • Norway

Arcoral Pharma (Arcoral Tab) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Arcoral Pharma (Arcoral Tab)‘s full profile, request access.

Request full access to PitchBook

Arcoral Pharma (Arcoral Tab) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Arcoral Pharma (Arcoral Tab)‘s full profile, request access.

Request full access to PitchBook